5/3/2013

Molecular breast imaging can identify 95% of cancers and locate ductal carcinoma and lobular carcinoma as well as lesions smaller than 1 centimeter, according to a study published in the European Journal of Nuclear Medicine and Molecular Imaging. The review also found that MBI's sensitivity for breast cancer was similar to that of MRI, but MBI has higher specificity and costs less. "Current evidence suggests that BSGI is an extremely useful adjunct to mammography for its ability to identify breast cancer with a high diagnostic performance," researchers said.

Related Summaries